speb/financial-data huggingface dataset:
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 611241000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1747073000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 611240000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1747073000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 611241000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1747073000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 611241000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2277178000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1747073000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 611240000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -389465000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -469028000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -168630000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 125120000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 2642458000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 1064172000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -469028000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -168630000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -1000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 29452000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 17066634000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 17066634000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -4093668000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 1578286000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 20007175000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 20007175000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1343320000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1343320000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 3869540000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1266976000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Normalized Income: 1768036717.89
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 611241000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 2619315000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Operating Income: 2980826000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 1019654000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 18194425000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 5826440000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 90657751.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 90657751.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1536130000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1536130000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 103055000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 103055000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 20792758000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 20792758000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1238872000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1238872000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 386809000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 168129000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 168129000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 97464000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 80515000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 4090993000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1244545000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 14014525000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 14014525000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 4957000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 4957000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 10856000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 10856000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Payables: 3345393000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 3345393000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 24760000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Pretax Income: 2329212000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 816786000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 22540000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -389465000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -4093668000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 8348324000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2830218000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1043351000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 281560000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 90657751.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 90657751.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Special Income Charges: -27949000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 21246047000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 21246047000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 20007175000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 20007175000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -6985282.11
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Tax Provision: 582139000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 205546000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 99352000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 99352000.00
AARTIPHARM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -469268000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 34817059000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 34817059000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 23104161000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 23104161000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 7543613000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 7543613000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 21246047000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 21246047000.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Total Expenses: 15213599000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4806786000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 13571012000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 13571012000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 20844141000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 20844141000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 4195311000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 4195311000.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -27949000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
AARTIPHARM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -27949000.00
AARTIPHARM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
AARTIPHARM.NS balance_sheet (annual, 2026-03-31) — Working Capital: 4597218000.00
AARTIPHARM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 4597218000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -736108000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 0.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -6997000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Amortization: 3737000.00
AARTISURF.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 3737000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 227408000.00
AARTISURF.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -22589000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 13796000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 164000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 426537000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 14834000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 551667000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Interest Income: 2905000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 2905000.00
AARTISURF.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 241153000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 52165000.00
AARTISURF.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 241153000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 2178765000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 2779000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 13233000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Other Payable: 70094000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Other Special Charges: 7060000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Preferred Securities Outside Stock Equity: 201448000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 275795000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 295363000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 1998000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 1998000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1283332000.00
AARTISURF.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 0.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 318587000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 333421000.00
AARTISURF.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 3508000.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00
AARTISURF.NS balance_sheet (annual, 2022-03-31) — Work In Process: 13111000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — +Operating Expense: 539224000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — +Total Revenue: 5972476000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 570100000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 653624000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -887241000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 194519000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -6997000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Amortization: 3737000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 3737000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 22311000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 7636000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Basic EPS: 16.64
AARTISURF.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 14291000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 279366000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -108534000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 0.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 79414000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 76226000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 76226000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -1000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 76226000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -25019000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Change In Payable: -155051000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -21384000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -201454000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 61934000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Common Stock: 79414000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 1680276000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 194141000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 78998000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 5108529000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Current Assets: 1823500000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Current Debt: 757894000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 757894000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1420504000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 5938000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Depreciation: 151132000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 154869000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 154869000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 151132000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 7714000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Diluted EPS: 16.47
AARTISURF.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 127045000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 162000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — EBIT: 324611000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — EBITDA: 479480000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — End Cash Position: 76225000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -76713000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 368061000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 136658000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 25133000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 935000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 660621000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 3037928000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Gross Profit: 863947000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Interest Expense: 146605000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 146605000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Interest Income: 2649000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 2649000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -139055000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 2649000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Inventory: 773263000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 2962892000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -106545000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 22311000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 194141000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 85058000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 0.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 524722000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 524722000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 2594506000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 194141000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Net Debt: 1206390000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -2421000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Net Income: 127045000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 127045000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 127045000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 127045000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 127045000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 178006000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 127045000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Net Interest Income: -145213000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 194141000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -131112000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -130650000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -145213000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 1000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -660000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2150687000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -108534000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -462000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 1679341000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 56453000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 145827000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 39060000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 479107000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Normalized Income: 126778785.46
AARTISURF.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 245192000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Operating Income: 324723000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Operating Revenue: 5972476000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 8476768.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 146157000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 83758000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 1600862000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 935000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 15095000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 134097000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -2000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: -1878000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 623699000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Payable: 18694000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Properties: 2071688000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 210826000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 196219000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Other Special Charges: -373000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Payables: 591494000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 14781000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Preferred Securities Outside Stock Equity: 208709000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 108901000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Pretax Income: 178006000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -108534000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 380906000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 5108529000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 154869000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 1556000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 1556000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 660000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 1406343000.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 194141000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 229498000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 254631000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Share Issued: 8476768.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Special Income Charges: 373000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1680276000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 1679341000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 106785.46
AARTISURF.NS income_statement (annual, 2023-03-31) — Tax Provision: 50961000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.29
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 0.00
AARTISURF.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -19000000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Total Assets: 4036491000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 2204998000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1282616000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1680276000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Total Expenses: 5647753000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2356215000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2212991000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 935711000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 1257000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 2538000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 373000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 373000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Work In Process: 9201000.00
AARTISURF.NS balance_sheet (annual, 2023-03-31) — Working Capital: 402996000.00
AARTISURF.NS income_statement (annual, 2023-03-31) — Write Off: 0.00
AARTISURF.NS income_statement (annual, 2024-03-31) — +Operating Expense: 517342000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — +Total Revenue: 5856154000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 673011000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 701072000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1050697000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 480322000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -12839000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Amortization: 934000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 29012000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 8007000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Basic EPS: 26.63
AARTISURF.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 76225000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 322571000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -163528000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 19830000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 84658000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 62490000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 62490000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -3000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 62490000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 153177000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Change In Payable: -218814000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 28296000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -37341000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -13734000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Common Stock: 84658000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2181097000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 289738000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 68926000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 4865730000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Current Assets: 1994970000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 3221000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Current Debt: 492912000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 496133000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1292134000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 34255000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Depreciation: 160375000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 160375000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 160375000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 159441000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 8477000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Diluted EPS: 25.16
AARTISURF.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 213270000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 158000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — EBIT: 461546000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — EBITDA: 621921000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — End Cash Position: 62490000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -371147000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 358078000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 356077000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 33434000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 7440000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 713912000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3204658000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Gross Profit: 990424000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Interest Expense: 139657000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 139657000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Interest Income: 1331000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 1331000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -132283000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 1331000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Inventory: 992077000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 2937363000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -162192000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 29012000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 289738000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 85058000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 16609000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 263354000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 279963000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2705978000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 289738000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Net Debt: 693776000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -1599000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Net Income: 213270000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 213270000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 213270000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 213270000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 213270000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 321889000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 213270000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Net Interest Income: -139005000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 0.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -526350000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -259821000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -139005000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 5000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Net PPE: 2153961000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -163528000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -266529000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2173657000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 75509000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 178401000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 454000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 630690000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Normalized Income: 219079967.50
AARTISURF.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 519605000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Operating Income: 473082000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Operating Revenue: 5856154000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 8476768.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 223846000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 40000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 2096439000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 7440000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 11386000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 127889000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 37710000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 75509000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: -3418000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 5842000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Payable: 11801000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Properties: 22125000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 58432000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 14271000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Payables: 692526000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15497000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Preferred Securities Outside Stock Equity: 215989000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 180244000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Pretax Income: 321889000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 5842000.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -163528000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 610632000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 4865730000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 160375000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 1412000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 1412000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 655000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 1616117000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 179520000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 212954000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Share Issued: 8476768.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Special Income Charges: -8769000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 2181097000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2173657000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -2959032.50
AARTISURF.NS income_statement (annual, 2024-03-31) — Tax Provision: 108619000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.34
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 0.00
AARTISURF.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -66497000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Total Assets: 4223093000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 2444451000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Total Debt: 776096000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 2181097000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Total Expenses: 5383072000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 2041996000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2228123000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 749862000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 679000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 7556000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -8769000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -8769000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Work In Process: 11981000.00
AARTISURF.NS balance_sheet (annual, 2024-03-31) — Working Capital: 702836000.00
AARTISURF.NS income_statement (annual, 2024-03-31) — Write Off: 8769000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 716705000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 840990000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 30296000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 18306000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 84658000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 9247000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 13075000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 84658000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 2221368000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 73388000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 2282730000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 2585000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 759780000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 762365000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1648308000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 58527000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 17439000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 2150925000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1016626000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 3333059000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 30296000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 15721000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 351911000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 367632000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 1102444000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 2150925000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 2203929000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 196301000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 8458495.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 388583000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 80001000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 2136710000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 17439000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 37256000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 85037000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 2077537000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 994000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 3828000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Payables: 716705000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 8458495.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 2221368000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 2203929000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 22462000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 4518646000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 2573279000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 1129997000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 2221368000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 2297278000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 2235916000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 648970000.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
AARTISURF.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 634422000.00
AARTISURF.NS income_statement (annual, 2025-03-31) — +Operating Expense: 1002023000.00
AARTISURF.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 250107000.00
AARTISURF.NS income_statement (annual, 2025-03-31) — +Total Revenue: 6590854000.00
AARTISURF.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2020541000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 922219000.00
AARTISURF.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 922219000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 762557000.00
AARTISURF.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 762557000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1223207000.00
AARTISURF.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1223207000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 480323000.00
AARTISURF.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 480323000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -14526000.00
AARTISURF.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -14526000.00
AARTISURF.NS income_statement (annual, 2025-03-31) — Amortization: 948000.00
AARTISURF.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 948000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 30325000.00
AARTISURF.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 30325000.00
AARTISURF.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 8456221.00
AARTISURF.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 8452348.00
AARTISURF.NS income_statement (annual, 2025-03-31) — Basic EPS: 17.20
AARTISURF.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 11.50
AARTISURF.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 62490000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 331332000.00
AARTISURF.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 331332000.00
AARTISURF.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -202812000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 16609000.00
AARTISURF.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 16609000.00
AARTISURF.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 84658000.00